Occupational exposure to antineoplastic drugs in seven Italian hospitals: The effect of quality assurance and adherence to guidelines

Journal of Oncology Pharmacy Practice

Volumn 17, Issue 4, 2011, Pages 320-332

  Turci, Roberta ^a   Minoia, Claudio ^a   Sottani, Cristina ^a   Coghi, Raffaella ^b   Severi, Paolo ^c   Castriotta, Cecilia ^c   Del Bianco, Massimo ^b   Imbriani, Marcello ^a,d  

^a IRCCS   (Italy)

^b Public Health Unit Ravenna   (Italy)

^c Public Health Unit Forlì   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

Antineoplastic drugs; monitoring strategies; occupational exposure; quality assurance

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; FLOXURIDINE; FLUOROURACIL; GEMCITABINE; IDARUBICIN; IFOSFAMIDE; PACLITAXEL; PLATINUM DERIVATIVE;

ARTICLE; BIOLOGICAL MONITORING; DRUG DETERMINATION; ENVIRONMENTAL MONITORING; HUMAN; ITALY; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; SAMPLING; WORKPLACE;

ANTINEOPLASTIC AGENTS; ENVIRONMENTAL MONITORING; GUIDELINE ADHERENCE; HEALTH PERSONNEL; HEALTH SURVEYS; HOSPITALS; HUMANS; ITALY; OCCUPATIONAL EXPOSURE; QUALITY ASSURANCE, HEALTH CARE;

EID: 82555189949     PISSN: 10781552     EISSN: 1477092X     Source Type: Journal    
DOI: 10.1177/1078155210381931     Document Type: Article

References (20)

1. National Institute for Occupational Safety and Health Alert. Preventing occupational exposure to antineoplastic and other hazardous drugs in healthcare settings. NIOSH Publication No. 2004-165.
2. Guidelines on handling hazardous drugs. Am J Health Syst Pharm. 2006 ; 63: 1172-1193
3. Turci R, Sottani C, Spagnoli G, Minoia C.. Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods. J Chromatogr B. 2003 ; 789: 169-209 (Pubitemid 36549189)
4. EURACHEM Guide. Middlesex, UK: AOAC International ; 1998 :
5. EURACHEM/CITAC Guide CG 4. 4, 2nd ed.Vienna: IAEA, 2000. Ellison SRL Rosslein M Williams A., ed. Vienna: IAEA ; 2000 :
6. Sottani C, Turci R, Perbellini L, Minoia C.. Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry. Rapid Commun Mass Spectrom. 1998 ; 12: 1063-1068 (Pubitemid 28370223)
7. Sottani C, Tranfo G, Bettinelli M, Faranda P, Spagnoli M, Minoia C.. Trace determination of anthracyclines in urine: a new high-performance liquid chromatography/tandem mass spectrometry method for assessing exposure of hospital personnel. Rapid Commun Mass Spectrom. 2004 ; 18: 2426-2436 (Pubitemid 39361782)
8. Sottani C, Zucchetti M, Zaffaroni M, Bettinelli M, Minoia C.. Validated procedure for simultaneous trace level determination of the anti-cancer agent gemcitabine and its metabolite in human urine by high-performance liquid chromatography with tandem mass spectrometry. Rapid Commun Mass Spectrom. 2004 ; 18: 1017-1023 (Pubitemid 38691363)
9. Sottani C, Tranfo G, Faranda P, Minoia C.. Highly sensitive high-performance liquid chromatography/selective reaction monitoring mass spectrometry method for the determination of cyclophosphamide and ifosfamide in urine of health care workers exposed to antineoplastic agents. Rapid Commun Mass Spectrom. 2005 ; 19: 2794-2800 (Pubitemid 41383363)
10. Sottani C, Turci R, Schierl R, Gaggeri R, Barbieri A, Violante FS, et al. Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high-performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurement. Rapid Commun Mass Spectrom. 2007 ; 21: 1289-1296 (Pubitemid 46506584)
11. Sottani C, Rinaldi P, Leoni E, Poggi G, Teragni C, Delmonte A, et al. Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation. Rapid Commun Mass Spectrom. 2008 ; 22: 2645-2659
12. Turci R, Fiorentino ML, Sottani C, Minoia C.. Determination of methotrexate in human urine at trace levels by solid phase extraction and high-performance liquid chromatogram/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2000 ; 14: 173-179 (Pubitemid 30079220)
13. Turci R, Micoli G, Minoia C.. Determination of methotrexate in environmental samples by solid phase extraction and high performance liquid chromatography: ultraviolet or tandem mass spectrometry detection?. Rapid Commun Mass Spectrom. 2000 ; 14: 685-691 (Pubitemid 30218010)
14. Micoli G, Turci R, Arpellini M, Minoia C.. Determination of 5-fluorouracil in environmental samples by solid-phase extraction and high performance liquid chromatography with ultraviolet detection. J Chromatogr B. 2001 ; 750: 25-32 (Pubitemid 33648326)
15. Spezia S, Bocca B, Forte G, Gatti A, Mincione G, Ronchi A, et al. Comparison of inductively coupled plasma mass spectrometry techniques in the determination of platinum in urine: quadrupole vs. sector field. Rapid Commun Mass Spectrom. 2005 ; 19: 1551-1556 (Pubitemid 40801999)
16. Minoia C, Turci R, Sottani C, Schiavi A, Perbellini L, Angeleri S, et al. Application of High Performance Liquid Chromatography/Tandem Mass Spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Commun Mass Spectrom. 1998 ; 12: 1485-1493 (Pubitemid 28485973)
17. Turci R, Sottani C, Ronchi A, Minoia C.. Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents. Toxicol Lett. 2002 ; 134: 57-64 (Pubitemid 35007286)
18. Acampora A, Castiglia L, Miraglia N, Pieri M, Soave C, Liotti F, et al. A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals. Ann Occup Hyg. 2005 ; 49: 611-618 (Pubitemid 41442686)
19. Hedmer M, Tinnerberg H, Axmon A, Jönsson BA.. Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. Int Arch Occup Environ Health. 2008 ; 81: 899-911
20. Yoshida J, Tei G, Mochizuki C, Masu Y, Koda S, Kumagai S.. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment. Ann Occup Hyg. 2009 ; 53: 153-160